Regent Pacific Group Limited (HKG:0575)

Market Cap	204.27M +94.4%
Revenue (ttm)	2.83M -49.5%
Net Income	-36.66M
EPS	-0.14
Shares Out	291.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,000
Average Volume	16,541
Open	0.7000
Previous Close	0.7300
Day's Range	0.7000 - 0.7000
52-Week Range	0.4000 - 1.2400
Beta	1.34
RSI	20.68
Earnings Date	Mar 26, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0575

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial numbers in USD